Government Subsidies Fail to Curb Premium Hikes as Pharmacy Benefit Manager Profits Rise: Billions in Funding Ineffective

Government subsidies aimed at stabilizing health insurance premiums have not prevented either premium increases or a rise in profits for Pharmacy Benefit Managers (PBMs). Billions of dollars in government funding have been allocated to PBMs, yet premiums continue to climb concurrently with PBM profitability. Specifically, the government has distributed billions of dollars to PBMs with the explicit goal of moderating the cost of health insurance premiums. Despite this financial intervention, premiums have not stabilized. At the same time, PBMs, which act as intermediaries between drug manufacturers, pharmacies, and health insurers, have experienced increasing profits during the same period in which they received government funding.

Newsflash | Powered by GeneOnline AI
Date: April 25, 2025

Related posts:

Breakthrough Study Suggests Common Antibiotic Vancomycin Could Treat Specific Inflammatory Bowel Disease Alzheimer’s Research: 16 New Susceptibility Genes Identified Study Reveals Startling Impact of Abrupt PEPFAR Funding Cuts Study Maps Brain’s Real-Time Speech Processing Using AI and Electrocorticography

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後